Sanguina has developed AnemoCheck and AnemoCheck Mobile, a new, disruptive point-of-care and in-home system that detects anemia in an inexpensive, simpler way.
Sanguina was established to develop and market AnemoCheck, a screening device, which is a rapid, accurate, inexpensive and disposable point-of-care test for anemia. It has been developed and extensively tested and should be available for marketing in early 2016.
Anemia is a major health concern, affecting approximately 2 billion people (30% of the world's population) annually. Anemia often co-exists with other disease states.